Fig. 1From: Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitisPatient disposition. Patients with only UC diagnostic codes related to diagnostic tests were excluded. N, number of patients meeting the inclusion/exclusion criteria; TNFi, tumour necrosis factor inhibitor; UC, ulcerative colitisBack to article page